Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Zolty David, Director. Director active across 1 company, notably Cell Source, Inc.. Cumulatively, 2 reports have been published. History available since 4 December 2017. The latest transaction was disclosed on 30 June 2021 (J). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
David Zolty is a Director at Cell Source, Inc., a company specializing in cell therapies. In this role, he contributes to the governance of the company and the development of its strategy. Zolty brings expertise in biotechnology and research, allowing him to play a key role in strategic decision-making. His commitment to innovation and improving healthcare is central to his mission.